A Multimodal Imaging Approach for Longitudinal Evaluation of Bladder Tumor Development in an Orthotopic Murine Model

Bladder cancer is the fourth most common malignancy amongst men in Western industrialized countries with an initial response rate of 70% for the non-muscle invasive type, and improving therapy efficacy is highly needed. For this, an appropriate, reliable animal model is essential to gain insight into mechanisms of tumor growth for use in response monitoring of (new) agents. Several animal models have been described in previous studies, but so far success has been hampered due to the absence of imaging methods to follow tumor growth non-invasively over time. Recent developments of multimodal imaging methods for use in animal research have substantially strengthened these options of in vivo visualization of tumor growth. In the present study, a multimodal imaging approach was addressed to investigate bladder tumor proliferation longitudinally. The complementary abilities of Bioluminescence, High Resolution Ultrasound and Photo-acoustic Imaging permit a better understanding of bladder tumor development. Hybrid imaging modalities allow the integration of individual strengths to enable sensitive and improved quantification and understanding of tumor biology, and ultimately, can aid in the discovery and development of new therapeutics.

[1]  Andrew Needles,et al.  Screening and quantification of the tumor microenvironment with micro-ultrasound and photoacoustic imaging , 2015, Nature Methods.

[2]  A. Goh,et al.  Novel endoscopic diagnosis for bladder cancer , 2015, Cancer.

[3]  B. Lopresti,et al.  In vivo imaging in an ABSL-3 regional biocontainment laboratory. , 2014, Pathogens and disease.

[4]  R. Askeland,et al.  Anti‐interleukin‐10R1 monoclonal antibody in combination with bacillus Calmette–Guérin is protective against bladder cancer metastasis in a murine orthotopic tumour model and demonstrates systemic specific anti‐tumour immunity , 2014, Clinical and experimental immunology.

[5]  Moustapha Hassan,et al.  Real-Time Assessment of Tissue Hypoxia In Vivo with Combined Photoacoustics and High-Frequency Ultrasound , 2014, Theranostics.

[6]  O. Oralkan,et al.  Photoacoustic Imaging of the Bladder , 2013, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[7]  A. Needles,et al.  Development and initial application of a fully integrated photoacoustic micro-ultrasound system , 2013, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.

[8]  W. Peter Vandertop,et al.  Functional multiplex reporter assay using tagged Gaussia luciferase , 2013, Scientific Reports.

[9]  Xi-hua Yang,et al.  A New Method of Establishing Orthotopic Bladder Transplantable Tumor in Mice , 2012, Cancer biology & medicine.

[10]  Jesse V Jokerst,et al.  Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via Raman imaging in living mice. , 2012, ACS nano.

[11]  Joseph C Liao,et al.  New optical imaging technologies for bladder cancer: considerations and perspectives. , 2012, The Journal of urology.

[12]  Wiendelt Steenbergen,et al.  Speed-of-sound compensated photoacoustic tomography for accurate imaging. , 2012, Medical physics.

[13]  Marleen Keyaerts,et al.  Bioluminescence imaging: looking beyond the light. , 2012, Trends in molecular medicine.

[14]  T. D. de Reijke,et al.  Best practice in the treatment of nonmuscle invasive bladder cancer , 2012, Therapeutic advances in urology.

[15]  S. Emelianov,et al.  Biomedical Applications of Photoacoustic Imaging with Exogenous Contrast Agents , 2012, Annals of Biomedical Engineering.

[16]  Zhixing Xie,et al.  Evaluation of bladder microvasculature with high-resolution photoacoustic imaging. , 2011, Optics letters.

[17]  F Stuart Foster,et al.  Micro-ultrasound for preclinical imaging , 2011, Interface Focus.

[18]  Molly Brewer,et al.  Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization. , 2011, Translational oncology.

[19]  Ronald B. Moore,et al.  Clinical Medicine Insights: Oncology Antitumor Efficacy of Intravesical Bcg, Gemcitabine, Interferon-α and Interleukin-2 as Mono-or Combination- Therapy for Bladder Cancer in an Orthotopic Tumor Model , 2022 .

[20]  W. See,et al.  MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin. , 2009, The Journal of urology.

[21]  W. Larchian,et al.  Optimizing orthotopic bladder tumor implantation in a syngeneic mouse model. , 2009, The Journal of urology.

[22]  W. Larchian,et al.  Mouse orthotopic models for bladder cancer research , 2009, BJU international.

[23]  Yusuke Inoue,et al.  Comparison of subcutaneous and intraperitoneal injection of d-luciferin for in vivo bioluminescence imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  Wiendelt Steenbergen,et al.  Real-time in vivo photoacoustic and ultrasound imaging. , 2008, Journal of biomedical optics.

[25]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. , 2008, European urology.

[26]  Ralph Weissleder,et al.  A secreted luciferase for ex vivo monitoring of in vivo processes , 2008, Nature Methods.

[27]  M. Gleave,et al.  A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging , 2007, BJU international.

[28]  A. Söling,et al.  Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model , 2007, BJU international.

[29]  J. Witjes Management of BCG failures in superficial bladder cancer: a review. , 2006, European urology.

[30]  Liang Cheng,et al.  Bladder cancer: epidemiology, staging and grading, and diagnosis. , 2005, Urology.

[31]  Robert M. Hoffman,et al.  The multiple uses of fluorescent proteins to visualize cancer in vivo , 2005, Nature Reviews Cancer.

[32]  Aaron Fenster,et al.  A new three-dimensional ultrasound microimaging technology for preclinical studies using a transgenic prostate cancer mouse model. , 2005, Cancer research.

[33]  C. Dinney,et al.  Intravesical Ad-IFNα Causes Marked Regression of Human Bladder Cancer Growing Orthotopically in Nude Mice and Overcomes Resistance to IFN-α Protein , 2004 .

[34]  M. O'Donnell,et al.  Immunotherapy of Experimental Bladder Cancer with Recombinant BCG Expressing Interferon-&ggr; , 2004, Journal of immunotherapy.

[35]  Meng Yang,et al.  Visualizing superficial human bladder cancer cell growth in vivo by green fluorescent protein expression , 2002, Cancer Gene Therapy.

[36]  S. Gambhir,et al.  Optical imaging of Renilla luciferase reporter gene expression in living mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Böhle,et al.  Optimizing syngeneic orthotopic murine bladder cancer (MB49). , 1999, Cancer research.

[38]  Masafumi Oshiro,et al.  Visualizing Gene Expression in Living Mammals Using a Bioluminescent Reporter , 1997, Photochemistry and photobiology.

[39]  R. Hoffman,et al.  Human RT‐4 bladder carcinoma is highly metastatic in nude mice and comparable ras‐H‐transformed RT‐4 when orthotopically onplanted as histologically intact tisuee , 1992, International journal of cancer.

[40]  R. Kerbel,et al.  Extensive multi‐organ metastasis following orthotopic onplantation of histologically‐intact human bladder carcinoma tissue in nude mice , 1991, International journal of cancer.

[41]  C. Dinney,et al.  Intravesical Ad-IFNalpha causes marked regression of human bladder cancer growing orthotopically in nude mice and overcomes resistance to IFN-alpha protein. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  Alberto Redaelli,et al.  The health economics of bladder cancer: a comprehensive review of the published literature. , 2003, PharmacoEconomics.

[43]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.